Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLN.L Regulatory News (SLN)

  • There is currently no data for SLN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

6 Aug 2021 12:13

RNS Number : 8829H
Silence Therapeutics PLC
06 August 2021
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00B9GTXM62

Issuer Name

SILENCE THERAPEUTICS PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Robert Quested

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

30-Jul-2021

6. Date on which Issuer notified

04-Aug-2021

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

7.840000

0.000000

7.840000

7010279

Position of previous notification (if applicable)

8.520000

0.000000

8.520000

7620279

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00B9GTXM62

7010279

7.840000

Sub Total 8.A

7010279

7.840000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

04-Aug-2021

13. Place Of Completion

Spain

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUNAARARUWRAR
Date   Source Headline
6th Oct 20107:00 amRNSForm 8.3 - Silence Therapeutics Plc
5th Oct 20102:08 pmRNSForm 8.3 - Silence Therapeutics PLC
4th Oct 20107:00 amRNSMP Healthcare Form 8.3 - Silence Therapeutics Plc
1st Oct 20103:19 pmRNSForm 8.3 - Silence Therapeutics plc
1st Oct 20107:00 amRNSForm 8.3 - Silence Therapeutics
30th Sep 20101:48 pmRNSForm 8.3 - [Silence Therapeutics]
29th Sep 20107:00 amPRNForm 8.3 - Silence Therapeutics plc
23rd Sep 20102:45 pmPRNForm 8.3 - Silence Therapeutics Plc
22nd Sep 20102:42 pmPRNForm 8.3 - Silence Therapeutics plc
21st Sep 20101:38 pmRNSForm 8.3 - Silence Therapeutics
20th Sep 20107:00 amRNSHalf Yearly Report
15th Sep 20102:54 pmPRNForm 8.3 - Silence Therapeutics plc
15th Sep 20107:00 amRNSMP Healthcare Form 8.3 - Silence Therapeutics Plc
14th Sep 20103:12 pmPRNForm 8.3 - Silence Therapeutics
14th Sep 201011:22 amRNSForm 8.3 - Silence Therapeutics plc
14th Sep 20109:45 amRNSForm 8.5 (EPT/NON-RI)
14th Sep 20107:00 amRNSChange of Adviser
13th Sep 20101:45 pmRNSForm 8.5 (EPT/NON-RI)
10th Sep 20103:24 pmRNSMP Healthcare Form 8.3 - Silence Therapeutics Plc
10th Sep 20102:06 pmRNSForm 8 (OPD) - Silence Therapeutics plc
10th Sep 201011:19 amRNSForm 8.5 (EPT/NON-RI)
9th Sep 201011:48 amRNSForm 8.5 (EPT/NON-RI)
8th Sep 20104:23 pmRNSForm 8.5 - Silence Therapeutics PLC
8th Sep 20103:12 pmPRNForm 8.3 - Silence Therapeutics PLC
8th Sep 20102:43 pmRNSForm 8.3 - SILENCE THERAPEUTICS PLC
8th Sep 20101:35 pmRNSForm 8.3 - [Silence Therapeutics Plc Amendment]
8th Sep 20101:02 pmRNSForm 8.3 - Silence Therapeutics plc
8th Sep 20101:00 pmRNSForm 8.3 - Silence Therapeutics Plc
8th Sep 201012:42 pmRNSForm 8.3 - [Silence Therapeutics Plc)
8th Sep 201011:09 amRNSForm 8.5 (EPT/NON-RI)
8th Sep 20107:00 amRNSNon Regulatory - Patent Issuance
7th Sep 20103:13 pmRNSForm 8.3 - Silence Therapeutics Plc
7th Sep 20102:41 pmRNSForm 8.3 - Silence Therapeutics plc
7th Sep 20102:39 pmPRNForm 8.3 - Silence Therapeutics Plc
7th Sep 201012:46 pmRNSForm 8.3 - Silence Therapeutics plc
7th Sep 201012:19 pmRNSForm 8.5 - Silence Therapeutics Plc (amendment)
7th Sep 201011:53 amRNSForm 8.5 - Silence Therapeutics
7th Sep 201010:58 amRNSForm 8.5 (EPT/NON-RI)
6th Sep 20104:40 pmRNSSecond Price Monitoring Extn
6th Sep 20104:35 pmRNSPrice Monitoring Extension
6th Sep 20103:14 pmRNSPotential Offer
19th Aug 20104:35 pmRNSExclusive option agreement with Novartis
18th Aug 20107:00 amRNSChange of Auditor and Notice of Interim Results
11th Aug 20107:00 amRNSZamore Patent Issuance
14th Jul 20102:32 pmRNSHolding(s) in Company
14th Jul 20107:00 amRNSCollaboraton extension with AstraZeneca
9th Jul 20104:35 pmRNSPrice Monitoring Extension
18th Jun 201012:51 pmPRNAll Resolutions Passed at Silence's (AIM: SLN) AGM
11th May 20107:00 amPRNSilence (AIM:SLN) to Present at Investor Conferences
29th Apr 20107:00 amPRNFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.